Artelo Biosciences, Inc. Common Stock (ARTL)
Artelo Biosciences, Inc. is a biotechnology company focused on developing novel therapies that target the endocannabinoid system to treat various conditions, including cancer, pain, and inflammation. The company's approach involves identifying and advancing small-molecule drugs that modulate cannabinoid receptors and related pathways. Founded with an emphasis on innovative research, Artelo Biosciences aims to improve patient outcomes by leveraging the therapeutic potential of the endocannabinoid system.
Company News
Artelo Biosciences, a clinical-stage pharmaceutical company, has priced a public offering of 441,210 common stock shares and pre-funded warrants, expecting to raise approximately $2.0 million to support its therapeutic development efforts.
Artelo Biosciences is conducting an underwritten public offering of common stock and pre-funded warrants, with R.F. Lafferty & Co., Inc. acting as the sole book-running manager.
Artelo Biosciences (ARTL) reports positive pre-clinical data from one of its FABP5 inhibitors in anxiety-related disorders. Stock up.
Penny stocks under $1 to watch right now. The post Best Penny Stocks To Buy Now? 7 Stocks Under $1 With Big News Today appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.